YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Predicting Outcomes


Dec. 2006/Jan. 2007 | Affymetrix and Iconix Biosciences have announced the launch of the ToxFX Analysis Suite, a toxicogenomics solution designed to improve researchers’ understanding of safety issues associated with drug candidates, compounds, or environmental toxicants. ToxFX combines Iconix’ automated analysis with Affymetrix’ GeneChip arrays, and helps scientists prioritize drug candidates and make preclinical development decisions. The software generates a safety profile that can diagnose or predict 50 toxicological outcomes and examine gene expression changes.

Product: ToxFX Analysis Suite

Company: Affymetrix and Iconix Biosciences

Available: Now

For more information: www.affymetrix.com, www.iconixbiosciences.com

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.